Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
An analysis of drug studies shows that most participants are white, even though trials are being done in more countries.
Life Science Alliance is a global, open-access, editorially independent, and peer-reviewed journal launched by an alliance of EMBO Press, Rockefeller University Press, and Cold Spring Harbor Laboratory Press.
It seems that CRISPR technology may indeed be all that it promises.
The breadth of social and moral questions raised requires a new architecture for democratic debate, insists Simon Burall.
If clinicians are expected to change their practice based on their reading of medical journals, they need to know that the evidence in published papers can be verified.
Why Google is celebrating the pioneer of medical and feminist history.
The US biomedical research agency NIH says it is dedicating $190 million over the next six years to researchers conducting gene-editing experiments, such as those with the powerful CRISPR technique.
A decision from the European Patent Office (EPO) has put the Broad Institute in Cambridge, Massachusetts, on shaky ground with its intellectual property claims to the gene-editing tool CRISPR.
As a culture and a profession, medicine continues to systematically disadvantage women physicians at every stage of their careers.
Six drug firms are paying to sequence the genes of every volunteer in the UK Biobank.
The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.
Technology could be used to wipe out malaria carrying mosquitos or other pests but UN experts say fears over possible military uses and unintended consequences strengthen case for a ban.
The National Academy of Sciences called on the federal government to make drastic policy changes to bring down the cost of prescription medicines.
Peer review decisions award >95% of academic medical research funding, so it is crucial to understand how well they work and if they could be improved.
When a clinical trial falters, doctors find themselves sifting through the rubble.
Adequate sample size is key to reproducible research findings: low statistical power can increase the probability that a statistically significant result is a false positive.
In this piece, I will explain how the explanation of the emergence of life could also explain the mechanism of Deep Learning.
A US Research Integrity Advisory Board is long overdue. Such a leadership body would mitigate bad practices and strengthen good research.
London’s loss, as a result of Brexit vote, is lamented by U.K. researchers
Missing trial results undermine pandemic preparedness